← SynDRA
AFIMOXIFENE
SynDRA canonical compound SYN0000411 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ESR2 |
|---|
| Mechanism of action | Selective estrogen receptor modulator |
|---|
All known targets
- ESR1
- ESR2
- CYP3A5
- ESRRG
- PLD1
- PRKCD
- PRKCE
- PRKCQ
- PRKCZ
Mechanisms of action (all sources)
- ESR1 ANTAGONIST
- Selective estrogen receptor modulator
- ESR1 MODULATOR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- RORA
- M4K2
- MDM2
- MDM4
- NPSR1
- NR1H2
- NR1I2
- NR4A2
- PPARD
- RAD52
- RARA
- RORC
- KCNH2
- RXRA
- SMAD2
- SMAD3
- THA
- TNNC1
- TNNI3
- TNNT2
- TRHR
- TSHR
- UBE2N
- KCNQ1
- JUN
- ACES
- CP19A
- ACM1
- ALR
- ANDR
- APAF
- BARD1
- BAZ2B
- BRCA1
- CASP3
- CASP7
- COT1
- CP2C9
- IFNG
Cross-references
Synonyms
- Afimoxifeno
- 4-hydroxytamoxifen
- 4-OHT
- Tamogel
- 4-Hydroxytamoxifen
- (Z)-4-Hydroxytamoxifen
- Hydroxytamoxifen
- 4-Monohydroxytamoxifen
- trans-4-Hydroxytamoxifen
- Ici 79280
- 4-OH-TAM
- (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol
- Z-4-hydroxytamoxifen
- UNII-95K54647BZ
- CHEMBL489
- ICI 79,280
- TAMOXIFEN, 4-HYDROXY-, (Z)-
- BRN 4910749
- (E/Z)-4-Hydroxy Tamoxifen
- MLS000069742
- C26H29NO2
- CHEBI:44616
- 95K54647BZ
- SMR000058939
- 4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol
- DTXCID802384
- DTXCID0028161
- 4OH-tamoxifen
- 4-OHT hydrotamoxifen
- RefChem:912611
- (E/Z)-4-Hydroxytamoxifen
- MFCD00468090
- R-LIPOIC ACID POTASSIUM COMPUND
- MFCD00278780
- (Z)-4-Hydroxy Tamoxifen
- [3H]4-OHT
- SR-01000759243
- Afimoxifene [USAN:INN]
- UNII-17197F0KYM
Look up AFIMOXIFENE in the interactive SynDRA portal →